803 related articles for article (PubMed ID: 22925498)
21. Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product.
Kallestrup EB; Jorgensen SS; Nordling J; Hald T
Scand J Urol Nephrol; 2005; 39(2):143-7. PubMed ID: 16032779
[TBL] [Abstract][Full Text] [Related]
22. Repeated onabotulinumtoxin-a injections provide better results than single injection in treatment of painful bladder syndrome.
Kuo HC
Pain Physician; 2013 Jan; 16(1):E15-23. PubMed ID: 23340540
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
[TBL] [Abstract][Full Text] [Related]
24. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
Chung SD; Kuo YC; Kuo HC
Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
[TBL] [Abstract][Full Text] [Related]
25. Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis.
Kuo HC
Urol Int; 2005; 75(2):170-4. PubMed ID: 16123573
[TBL] [Abstract][Full Text] [Related]
26. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
[TBL] [Abstract][Full Text] [Related]
27. A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis.
Cervigni M; Natale F; Nasta L; Padoa A; Voi RL; Porru D
Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jul; 19(7):943-7. PubMed ID: 18338095
[TBL] [Abstract][Full Text] [Related]
28. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL
Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012
[TBL] [Abstract][Full Text] [Related]
29. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
[TBL] [Abstract][Full Text] [Related]
30. Maintenance of the response to dimethyl sulfoxide treatment using hyperbaric oxygen in interstitial cystitis/painful bladder syndrome: a prospective, randomized, comparative study.
Gallego-Vilar D; García-Fadrique G; Povo-Martin I; Salvador-Marin M; Gallego-Gomez J
Urol Int; 2013; 90(4):411-6. PubMed ID: 23485788
[TBL] [Abstract][Full Text] [Related]
31. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
[TBL] [Abstract][Full Text] [Related]
32. Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis.
Nickel JC; Tripp D; Teal V; Propert KJ; Burks D; Foster HE; Hanno P; Mayer R; Payne CK; Peters KM; Kusek JW; Nyberg LM;
J Urol; 2007 May; 177(5):1832-6. PubMed ID: 17437831
[TBL] [Abstract][Full Text] [Related]
33. A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis.
Tutolo M; Ammirati E; Castagna G; Klockaerts K; Plancke H; Ost D; Van der Aa F; De Ridder D
Int Braz J Urol; 2017; 43(1):134-141. PubMed ID: 28124536
[TBL] [Abstract][Full Text] [Related]
34. Intravesical Bacillus Calmette-Guerin for treatment of refractory interstitial cystitis.
Aghamir SM; Mohseni MG; Arasteh S
Urol J; 2007; 4(1):18-23. PubMed ID: 17514606
[TBL] [Abstract][Full Text] [Related]
35. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review.
Toft BR; Nordling J
Curr Opin Urol; 2006 Jul; 16(4):268-72. PubMed ID: 16770126
[TBL] [Abstract][Full Text] [Related]
36. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
Kuo HC
Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and urodynamic experience with intravesical hyaluronic acid in painful bladder syndrome associated with interstitial cystitis].
Figueiredo AB; Palma P; Riccetto C; Herrmann V; Dambros M; Capmartin R
Actas Urol Esp; 2011 Mar; 35(3):184-7. PubMed ID: 21397161
[TBL] [Abstract][Full Text] [Related]
38. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.
Payne CK; Mosbaugh PG; Forrest JB; Evans RJ; Whitmore KE; Antoci JP; Perez-Marrero R; Jacoby K; Diokno AC; O'Reilly KJ; Griebling TL; Vasavada SP; Yu AS; Frumkin LR;
J Urol; 2005 May; 173(5):1590-4. PubMed ID: 15821499
[TBL] [Abstract][Full Text] [Related]
39. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
Kuo HC; Chancellor MB
BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
[TBL] [Abstract][Full Text] [Related]
40. The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review.
Han XM; Wu XH; Li B; Pan F; Li WC; Liu SL; Zeng FQ; Chen M
Taiwan J Obstet Gynecol; 2015 Jun; 54(3):240-7. PubMed ID: 26166334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
